Proinflammatory cytokines changes in clinical course of acute myocardial infarction
https://doi.org/10.20538/1682-0363-2017-1-92-100
Abstract
Purpose: to evaluate the interrelationships of proinflammatory cytokines serum levels with the development of acute myocardial infarction (MI) complications.
Materials and methods. Eighty two patients with AMI were studied. Prospective short-term study included, patients with uncomplicated non-Q wave MI (n = 27), patients with Q-wave MI complicated by acute left ventricular insufficiency Killip class I–II (n = 30), patients with Q-wave MI complicated by acute left ventricular insufficiency Killip class III–IV (n = 17), non-survivors due to development of cardiogenic shock (n = 8) and age and gender matched healthy controls (n = 12). Serum levels of IL-1β, IL-6 and TNF-α had been evaluated by means of ELISA method. Blood samples had been drawn on admission to the hospital within 18–28 hours from the onset of symptoms, at 3d and 14th days of MI. Risk stratification was assessed on admission according to the GUSTO Score.
Results. All cytokines levels were significantly elevated in MI patients in comparison to controls. Mean concentrations of IL-6 at baseline were higher among patients with MI complicated by cardiogenic shock than in group with uncomplicated MI (27,45 vs 16,04 pg/mL; р < 0,001). The same was revealed in concentration of TNF-α (24,74 vs 19,58 pg/mL; р < 0,01), while mean concentration of IL-1β did not differ significantly between these two groups. Non-survivors also showed significantly higher levels of IL-6, TNF-α than all groups of survived patients.
Conclusions. Increased levels of IL-6 and TNF-α at 1-st day of MI are associated with the development of acute left ventricular insufficiency and unfavorable prognosis.
About the Authors
O. V. Soldatova
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Assistant of the Internal Medicine 1 Department,
5/7, Lenina Av., Simferopol 295051, Republic of Crimea
A. V. Kubyshkin
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
DM, Professor, Head of the General and Clinical Pathophysiology Department,
5/7, Lenina Av., Simferopol 295051, Republic of Crimea
A. V. Ushakov
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
DM, Professor, Head of the Internal Medicine 1 Department,
5/7, Lenina Av., Simferopol 295051, Republic of Crimea
A. I. Gordienko
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
PhD, Senior Researcher of CNRL,
5/7, Lenina Av., Simferopol 295051, Republic of Crimea
I. I. Fomochkina
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
DM, Professor of General and Clinical Pathophysiology Department,
5/7, Lenina Av., Simferopol 295051, Republic of Crimea
A. A. Gagarina
Medical Academy named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
PhD, Associate Professor of the Internal Medicine 1 Department,
5/7, Lenina Av., Simferopol 295051, Republic of Crimea
References
1. Libby P., Ridker M.P., Hansson K.G. Inflammation in atherosclerosis. From pathophysiology to practice // J. Am. Coll. Cardiol. 2009; 54: 21–29.
2. Litvin E.I. Rol mediatorov vospaleniya v patogenese ostrogo coronarnogo syndroma [The role of inflammatory mediators in pathogenesis of acute coronary syndrome] // Vrachebnaya practika – Doctor’s practice. 2005; 4: 31–34. (in Russian).
3. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease // N. Engl. J. Med. 2005; 352: 1685–1695.
4. Bodi V., Sanchis J., Nunez J.. Uncontrolled immune response in acute myocardial infarction: unraveling the thread // Am. Heart. J. 2008; 156(6): 1065–1073.
5. Chukaeva I.I., Bogova O.T., Korochkin I.M. et al. Infarct myocarda I vospalenie [Myocardial infarction and inflammation] // Medicina neotlojnih sostoyaniy – Medical Emergency Conditions. 2007; 4 (11): 19–23 (in Russian).
6. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction // J. Am. Coll. Cardiol. 2007; 50: 2173–2195.
7. Aymong E.D. et al. Pathophysiology of cardiogenic shock complicating acute myocardial infarction // Med. Clin. North. Am. 2007; 91(4): 701–12; XII.
8. Talaeva TV, Bratus VV. Rol systemnogo vospaleniya v razvitii ostrogo coronarnogo syndrome [Role of systemic inflammation in the development of acute coronary syndrome] // Ukrainskiy kardiologicheskiy jurnal – Ukrainian Journal of Cardiology. 2009; Dodatok 1: 218–240 (in Russian).
9. Chereshnev V.A., Gusev E.Yu. Immunologicheskie i patofisiologicheskie mehanizmi sistemnogo vospaleniya [Immunological and pathophisiological mechanisms of systemic inflammation] // Medicinskaya immunologiya – Medical Immunology. 2012; 14 (1–2): 9–20.
10. Mezhirova NM, Danilova VV, Ovcharenko SS. Patofisiologicheskie I diagnosticheskie aspect syndrome systemnogo dospalitelnogo onveta [Pathophysiological and diagnostic aspects of systemic inflammatory response syndrome] // Medicina neotlojnih sostoyaniy – medical Emergency Conditions. 2011; 1 (2): 32–33 (in Russian).
11. Passoni F., Morelli В., Seveso G. et al. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes // Ital. Heart J. 2002; 3: 28–35.
12. Chukaeva I.I., Orlova N.V., Spiryakina Ya.G. et al. Izuchenie cytokinovoi aktivnosti u bolnyh ostrym infarctom myokarda [Study of cytokine activity in patients with acute myocardial infarction] // Rossiyskiy kardiologicheskiy jurnal – Russian Journal of Cardiology. 2010; 4: 5–10. ( in Russian).
13. Liaudet L., Rosenblatt-Velin N. Role of innate immunity in cardiac inflammation after myocardial infarction // Front. Biosci (Schol. Ed.) 2013; 5: 86–104.
14. Kachkovskii M.A., Rogozina E.J., Chekuldaeva L.E., Suvorov A.E. Ocenka vlijanija intensivnosti sistemnoy vospalitelnoy reakcii na razmer nekroza miokarda po dannym morfometricheskogo issledovanija [Assessing the impact intensity of systemic inflammatory response to the size of myocardial necrosis according to morphometric study] // Morfologicheskie vedomosti – Morphological Gazette. 2013; (3): 53–6 (in Russian).
15. Teplyakov A.T., Grakova E.V., Berezikova E.N., Shilov S.N., Kopieva K.V., Kalyuzhin V.V. Rannie marker progressirovanija serdechnoi nedostatochnosti I apoptoza [Early markers of progression of heart failure and apoptosis: their role in predicting the risk of adverse cardiovascular events in patients with prior myocardial infarction] // Bulleten sibirskoy mediciny – Bulletin of Siberian Medicine. 2016; 15 (1): 37–46 (in Russian).
16. Seropian I.M., Toldo S., Van Tassell B.W., Abbate A. (2014) AntiInflammatory Strategies for Ventricular Remodeling Following ST Segment Elevation Acute Myocardial Infarction // J. Am. Coll. Cardiol. 63: 1593–1603.
17. Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology // Eur. Heart J. 2008; 29: 2909–2945.
18. Antman E.M., Hand M., Armstrong P.W. et al. 2007 Focused Update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee // Circulation. 2008; 117: 296–329.
19. Diagnostika I lechenie bolnyh ostrym infarktom myokarda s podemom segmenta ST [Diagnostic and Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: Russian guidelines report of the Russian scientific cardiologic society] // Kardiovaskuljarnaja terapija I profilaktika – Cardiovascular therapy and prevention. 2007; 6 (8): 1–66 (in Russian).
20. Neskovic A.N., Otasevic P., Bojic M., Popovic A.D. Association of Killip class on admission and left ventricular dilatation after myocardial infarction: a closer look into an old clinical classification // Am. Heart J. 1999; 137: 361–7.
21. Khot U.N., Jia G., Moliterno D.J., et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification // JAMA. 2003; 290: 2174–81.
22. Fox K.A., Goodman S.G., Klein W. et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE) // Eur. Heart J. 2002; 23: 1177–1189.
23. Yakushin S.S., Furmenko G.I., Anikina S.A. Epidimiologicheskie osobennosti ostroy koronarnoy patologii u jenschin [Epidemiological peculiarities of acute coronary pathology in women. Trial RESONANS results] // Problemi jenskogo zdorovija – Problems of women health. 2010: 2 (5): 5–11 (in Russian).
24. Novikova N.A., Gendlin G.E., Storoghakov G.I. Gendernye razlichija u bolnyh ostrym infarktom miokarda [Gender differences in patients with acute coronary syndrome] // Serdechnaja nedostatochnost – Heart falure. 2008: 3 (47): 137–143 (in Russian).
25. Lee P.Y., Alexander K.P., Hammill B.G. et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes // JAMA. 2001; 286: 708–713.
26. Wenger N. K. Clinical characteristics of coronary heart disease in women, emphasis on gender differences // Cardiovasc. Res. 2002; 53: 558–567.
27. Rebrova O.Yu. Statisticheskiy analiz medicinskih dannyh [Statistical analysis of medical data. The use of the application package STATISTICA] // M.: MediaSfera Publ., 2002: 312 (in Russian).
28. Organov R.G., Zakirova N.E., Zakirova A.N. et al. Immunovospalitelnye reakcii pri ostrom koronarnom syndrome [Immuno-inflammatory responses in acute coronary syndrome] // Racionalnaja farmakoteratija v kardiologii- Rational pharmacotherapy in cardiology. 2007; 5: 15–19 (in Russian).
29. Kinlay S., Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy // Am. J. Cardiol. 1997; 80: 11I–16I.
30. Ehrin J.A., David A.M., Morrow M.D. et al. Inflammatory biomarkers in Acute Coronary Syndroms. Part I // Circulation. 2006; 113: 763.
31. Neri M., Fineschi V., Di Paolo M., Pomara C., Riezzo I., Turillazzi E., Cerretani D. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction // Curr. Vasc. Pharmacol. 2015; 13 (1): 26–36.
32. Pavlikova E.P., Merai I.A. klinicheskoe znachenie interleykina-6 I faktora nekroza opuholi pri ishemicheskoi bolezni serdca [Clinical value of interleukin-6 and tumor necrosis factor in ischemic heart disease] // KardiologijaCardiology. 2003; 8: 68–71 (in Russian).
33. Lindmark E., Diderholm E., Wallentin L., Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy // JAMA. 2001; 286: 2107–13.
34. Feldman A.M. The role of tumor necrosis factor in the pathophysiology of heart failure // J. Am. Coll. Cardiol. 2000; 35: 537–544.
35. Konstantinova E.V., Konstantinova N.A. Kletochnye I molekuljarnye mehanizmy vospalenija v patogeneze infarkta miokarda [Cellular and molecular mechanisms of inflammation in pathogenesis of myocardial infarction] // Bulleten RGMU – Bulletin of RSMU/ 2010; (1): 60–64 (in Russian)
Review
For citations:
Soldatova O.V., Kubyshkin A.V., Ushakov A.V., Gordienko A.I., Fomochkina I.I., Gagarina A.A. Proinflammatory cytokines changes in clinical course of acute myocardial infarction. Bulletin of Siberian Medicine. 2017;16(1):92-100. (In Russ.) https://doi.org/10.20538/1682-0363-2017-1-92-100
Views:
1796
Email this article 